Roche posts higher sales on growth scross pharma, diagnostics units
Roche reiterated its full-year guidance and said it is prepared to launch its giredestrant breast-cancer pill later this year.
We haven't written up this one. Hindustan Times - World News has the full story — the link below goes straight to it.